Ellen redesigned her relationship with eating after experiencing relief from “food noise” while on medication. She spent 16 weeks on the drug before beginning a six-week taper, ultimately losing 22kg. She found that as she lost weight, she was able to exercise more and replace emotional eating with physical activity, “rather of going to the cupboards and filling my face,” she would go for a run.
However, when Ellen stopped taking Mounjaro, her weight began to creep back up, a advancement she described as “messed my head up a little bit.” This experience underscores a critical point: the importance of ongoing support, according to Dr.al-Zubaidi. The UK’s National Institute for Health and Care Excellence (NICE) has recommended that patients receive at least one year of continued advice and personalized action plans after ending treatment. This support aims to help individuals make lasting lifestyle changes to maintain weight loss and overall health.
A: No. While medications like Mounjaro can be effective, they are most successful when combined with lifestyle changes and ongoing support to prevent weight regain after stopping treatment.
But this level of support isn’t always available, particularly for those who fund the medications privately, like Ellen and Tanya. tanya, who has been taking the medication for an unspecified period, reports that its impact has diminished in recent months, yet she’s hesitant to stop.
“For the frist 38 years of my life, I was overweight – now I’m six stone (38kg) lighter,” Tanya said. She admits to feeling a sense of “addiction” to the medication, driven by the positive feelings and control it provides. She paused, then wondered if perhaps it’s not an addiction *to* the medication, but rather the medication *controlling* her.
She’s tried to discontinue the medication several times, but the fear of regaining the weight quickly compels her to resume treatment. This cycle highlights the psychological challenges that can accompany these medications and the need for thorough support systems.
The Role of Long-Term Support
The NICE proposal emphasizes the need for a holistic approach to weight management, extending beyond the period of active medication use. Tailored action plans and ongoing advice can empower individuals to adopt enduring habits and navigate the challenges of maintaining weight loss.
Without this continued support, individuals may find themselves caught in a cycle of medication dependence and weight fluctuation, as illustrated by Tanya’s experience.
losing 22 kilograms (3 stone 7 pounds) is a significant achievement, but maintaining that loss is proving a challenge for some patients coming off newer weight-loss medications like Mounjaro, raising questions about long-term support needs. The experience highlights the complex interplay between medication, lifestyle changes, and the potential for reliance.
The Weight Loss Plateau: What Happens When the Medication Stops?
For individuals who achieve success with drugs like Mounjaro, stopping treatment can trigger weight regain, underscoring the need for sustained guidance and behavioral support.